Trial Profile
A Multicenter, Randomized, Double-blind, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tadalafil/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 12 Oct 2016 Status changed from active, no longer recruiting to completed.
- 12 Feb 2016 New trial record